Online Inquiry
Cat.#: ACPP-1351
| Despition | Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1681 | Human CALN1 Protein (AC1681) | 1 µg | inquiry |
| ACPP-1429 | Human FGF14 Protein (AC1429) | 2 µg | inquiry |
| ACPP-1772 | Human CALB2 Protein (AC1772) | 5 µg | inquiry |
| ACPP-1655 | Human RAB23 Protein (AC1655) | 5 µg | inquiry |
| ACPP-1073 | Dopamine D5 Receptor Blocking Peptide (AC1073) | 250 µg | inquiry |
| ACPP-1251 | EAAT2 Blocking Peptide (AC1251) | 250 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
| ACPP-1055 | Recombinant Human TIMP1 Protein (Fc Tag) (AC1055) | 50 µg | inquiry |
| ACPP-1229 | Mouse Leptin Protein (AC1229) | 200 µg | inquiry |
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.